The AHA, 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers July 9 filed an amicus brief in a federal district court in Maryland, defending the state’s law protecting 340B pricing for contract pharmacy arrangements. AHA, 340B Health and the West Virginia Hospital Association last week filed a similar amicus brief in a federal district court in West Virginia.  
 
The AHA filed last month similar briefs in Maryland and Mississippi. On July 1, a Mississippi judge denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of Mississippi's law on 340B pricing protection for contract pharmacy arrangements.

Related News Articles

Headline
The AHA, 340B Health, the Minnesota Hospital Association and American Society of Health-system Pharmacists Oct. 4 filed an amicus brief in the U.S. District…
Headline
A Louisiana district court Sept. 30 upheld a state law prohibiting drug companies from denying Louisiana hospitals 340B discounts for drugs dispensed at…
Headline
Johnson & Johnson Sept. 30 notified the Health Resources and Services Administration that it is ceasing implementation of its proposed 340B rebate model.…
Headline
The Health Resources and Services Administration Sept. 27 sent a final warning letter to Johnson & Johnson urging the company to inform the agency by…
Headline
“As pharmaceutical companies throw stone after stone at the 340B program, they should beware of their own glass house. Their complaints ring hollow when it is…
Headline
The Health Resources and Services Administration Sept. 17 told Johnson & Johnson that the company’s publicly announced plans to implement a 340B rebate…